> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide for Methylphenidate Hydrochloride ANDAs
- URL: https://www.fdaweb.com/draft-guide-for-methylphenidate-hydrochloride-andas/
- Published: 2017-10-23T12:00:00.000Z
- Updated: 2026-09-14T22:57:34.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139942

*Federal Register* notice: FDA has made available a new draft guidance for industry on generic methylphenidate hydrochloride oral extended-release tablets. When finalized, the document will provide product-specific recommendations on, among other things, the design of bioequivalence studies to support ANDAs for such products. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-23/pdf/2017-22891.pdf?ref=fdaweb.com).